Renzapride

  Renzapride is a full serotonin 5-HT₄ receptor agonist, partial serotonin 5-HT₃ receptor antagonist.

Additional recommended knowledge

Correct Test Weight Handling Guide: 12 Practical Tips

Guide to balance cleaning: 8 simple steps

Recognize and detect the effects of electrostatic charges on your balance

Clinical Uses

Renzapride is currently in Phase III clinical development in the United States for the treatment of constipation-predominant irritable bowel syndrome (IBS-C). It is also potentially effective for irritable bowel syndrome with alternating stool pattern (IBS-A). It is being developed by Alizyme of the UK.